Anders Lindblad
Overview
Explore the profile of Anders Lindblad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
451
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lindblad A, de Monestrol I, Gilljam M, Krantz C, McGarry L, Banefelt J, et al.
J Med Econ
. 2024 Jun;
27(1):897-906.
PMID: 38939921
Aims: We aimed to describe the clinical, economic, and societal burdens of cystic fibrosis (CF) and impact of CF transmembrane conductance regulator modulator (CFTRm) treatment on people with CF, caregivers,...
2.
Wahlgren L, Kroksmark A, Lindblad A, Tulinius M, Sofou K
J Neurol
. 2024 Apr;
271(7):4300-4309.
PMID: 38630313
Background: Duchenne muscular dystrophy (DMD) is a neuromuscular disorder with progressive decline of pulmonary function increasing the risk of early mortality. The aim of this study was to explore the...
3.
Colombo C, Ramm G, Lindblad A, Corti F, Porcaro L, Alghisi F, et al.
J Cyst Fibros
. 2023 Feb;
22(2):263-265.
PMID: 36739240
Cystic-fibrosis-related liver disease (CFLD) is a variable phenotype of CF. The severe CFLD variant with cirrhosis or portal hypertension has a poor prognosis and life expectancy. CFTR modulator therapies are...
4.
Sandvik R, Lindblad A, Robinson P, Nielsen K, Gustafsson P
J Appl Physiol (1985)
. 2022 Dec;
134(2):316-327.
PMID: 36548514
Cystic fibrosis (CF) lung disease is characterized by increased ventilation inhomogeneity (VI), as measured by multiple-breath washout (MBW). Lung clearance index (LCI) is the most reported VI outcome. This study...
5.
Orenti A, Mei-Zahav M, Boracchi P, Lindblad A, Shteinberg M
J Cyst Fibros
. 2022 Aug;
22(1):103-111.
PMID: 36045028
Background: Long-term treatment with inhaled antibiotics is recommended for people with cystic fibrosis (pwCF) chronically infected with Pseudomonas aeruginosa (PA). However, pwCF without chronic PA infection are also commonly treated...
6.
Blomquist A, Inghammar M, Al Shakirchi M, Ericson P, Krantz C, Svedberg M, et al.
BMC Pulm Med
. 2022 Jul;
22(1):263.
PMID: 35790954
Background: Aspergillus fumigatus is the most common filamentous fungus isolated from the airways of people with cystic fibrosis (CF). The aim of this study was to investigate how chronic A....
7.
Svedberg M, Imberg H, Gustafsson P, Tiddens H, Davies G, Lindblad A
Thorax
. 2022 Mar;
78(2):176-182.
PMID: 35277449
No abstract available.
8.
Svedberg M, Imberg H, Gustafsson P, Brink M, Caisander H, Lindblad A
Acta Paediatr
. 2022 Feb;
111(6):1253-1260.
PMID: 35181935
Aim: Annual chest X-ray is recommended as routine surveillance to track cystic fibrosis (CF) lung disease. The aim of this study was to investigate the clinical utility of chest X-rays...
9.
Sandvik R, Gustafsson P, Lindblad A, Buchvald F, Olesen H, Olsen J, et al.
Pediatr Pulmonol
. 2022 Jan;
57(4):945-955.
PMID: 35029068
Introduction: Multiple breath washout (MBW) is used for early detection of cystic fibrosis (CF) lung disease, with SF MBW commonly viewed as the reference method. The use of N MBW...
10.
Sandvik R, Gustafsson P, Lindblad A, Robinson P, Nielsen K
J Appl Physiol (1985)
. 2021 May;
131(1):107-118.
PMID: 34043468
Recent studies indicate limited utility of nitrogen multiple-breath washout (NMBW) in infancy and advocate for using sulfur hexafluoride (SF) MBW in this age-group. Modern NMBW systems, such as EXHALYZER D...